GLOBAL VACCINE RESEARCH COLLABORATIVE - HEALTH
News: India urges G-20 countries to join vaccine research collaborative in
wake of COVID vaccine inequity
What is in the news?
● Recently,
India has said that it is working in partnership with two leading global
non-profits to convene and build consensus among the G-20 member States and
others, for a proposed Global Vaccine Research Collaborative.
Key takeaways from the news:
● India
said that International cooperation is essential to advance vaccine development
for emerging pathogens.
● The
G-20 can serve as a vital platform to facilitate collaboration between
governments, research organisations, pharmaceutical companies, and other stakeholders.
● The
Department of Pharmaceuticals is
working with the non-profit Program for
Appropriate Technology in Health (PATH) and the Coalition for Epidemic Preparedness Innovations (CEPI) to build
consensus for the proposed Collaborative not just among G-20 nations, but the
special invitee countries as well.
Global Vaccine Research Collaborative:
About:
● India
has proposed this research initiative in the G-20 health working group.
Objectives:
● To
address the vaccine gap and enable equitable access to vaccines at the global
stage,
● Addressing
major gaps in vaccine R&D before the next pandemic,
● Establishing
a structure and principles for better preparedness,
● Creating
a mechanism to improve coordination and foster an enabling environment for
vaccine R&D.